Neoplastic meningitis surgery: Difference between revisions

	Neoplastic meningitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Neoplastic Meningitis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X-Ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Neoplastic meningitis surgery On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Neoplastic meningitis surgery All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Neoplastic meningitis surgery
CDC on Neoplastic meningitis surgery
Neoplastic meningitis surgery in the news
Blogs on Neoplastic meningitis surgery
Directions to Hospitals Treating Choroid plexus papilloma
Risk calculators and risk factors for Neoplastic meningitis surgery

Revision as of 21:16, 22 January 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Surgery is not the first-line treatment option for patients with neoplastic meningitis.
Indications for surgery include:^[1]

Administration of cytotoxic drugs by placement of an intraventricular catheter and a subgaleal reservoir
Placement of a ventriculoperitoneal shunt (VPS) in patients with symptomatic hydrocephalus

↑ Chamberlain, M. C. (2008). "Neoplastic Meningitis". The Oncologist. 13 (9): 967–977. doi:10.1634/theoncologist.2008-0138. ISSN 1083-7159.

@@ Line 9: / Line 9: @@
 *Indications for surgery include:<ref name="Chamberlain2008">{{cite journal|last1=Chamberlain|first1=M. C.|title=Neoplastic Meningitis|journal=The Oncologist|volume=13|issue=9|year=2008|pages=967–977|issn=1083-7159|doi=10.1634/theoncologist.2008-0138}}</ref>
 :*Administration of cytotoxic drugs by placement of an intraventricular catheter and a subgaleal reservoir
-:*Placement of a ventriculoperitoneal shunt (VPS) in patients with [[hydrocephalus|symptomatic hydrocephalus]].
+:*Placement of a ventriculoperitoneal shunt (VPS) in patients with [[hydrocephalus|symptomatic hydrocephalus]]
 ==References==